buprenorphin/naloxon "mylan" 8+2 mg resoribletter, sublinguale
mylan ab - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 8+2 mg
betahistine "stada" 16 mg tabletter
stada arzneimittel ag - betahistindihydrochlorid - tabletter - 16 mg
betahistine "stada" 24 mg tabletter
stada arzneimittel ag - betahistindihydrochlorid - tabletter - 24 mg
betahistine "stada" 8 mg tabletter
stada arzneimittel ag - betahistindihydrochlorid - tabletter - 8 mg
natriumoxybat "ascend" 500 mg/ml oral opløsning
ascend gmbh - natriumoxybat - oral opløsning - 500 mg/ml
natriumoxybat "kalceks" 500 mg/ml oral opløsning
kalceks as - natriumoxybat - oral opløsning - 500 mg/ml
natriumoxybat "reig jofre" 500 mg/ml oral opløsning
laboratorio reig jofre s.a. - natriumoxybat - oral opløsning - 500 mg/ml
libroxar 2+0,5 mg resoribletter, sublinguale
laboratoires smb s.a. - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 2+0,5 mg
libroxar 8+2 mg resoribletter, sublinguale
laboratoires smb s.a. - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 8+2 mg
fampridine accord
accord healthcare s.l.u. - fampridine - multipel sclerose - andre narkotika stoffer - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).